Cegarra, Céline http://orcid.org/0000-0002-1710-9796
Chaves, C.
Déon, C.
Do, T. M.
Dumas, B.
Frenzel, A.
Kuhn, P.
Roudieres, V.
Guillemot, J. C.
Lesuisse, D.
Funding for this research was provided by:
Sanofi
Innovative Medicines Initiative (COMPACT)
Article History
Received: 29 November 2021
Accepted: 4 March 2022
First Online: 21 March 2022
Declarations
:
: Experiments were performed at Sanofi in our Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC)-accredited facility in full compliance with standards for the care and use of laboratory animals, according to the French and European Community (Directive 2010/63/EU) legislation. All procedures were approved by the local animal ethics committee [Ethical Committee on Animal Experimentation (CEEA) #24 and #21], of Sanofi, Vitry-Alfortville and Chilly Mazarin Research Centers, France, and the French Ministry for Research.
: Not applicable.
: The authors declare that they have no competing interests.